Post Dural Puncture Headache Unknown Status Phase 2 Trials for Midazolam (DB00683)

IndicationStatusPhase
DBCOND0042494 (Post Dural Puncture Headache)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01503788Bedside Sedation for the Prevention of Post Dural Puncture HeadacheTreatment